Genpact Framtida tillväxt
Future kriterier kontrolleras 1/6
Genpact förväntas öka intäkter och intäkter med 9.2% respektive 7% per år. EPS förväntas tillväxt med 10.2% per år. Avkastningen på eget kapital förväntas bli 17.4% om 3 år.
Viktig information
9.2%
Tillväxttakt i vinsten
10.20%
Tillväxttakt för EPS
| Professional Services vinsttillväxt | 15.3% |
| Intäkternas tillväxttakt | 7.0% |
| Framtida avkastning på eget kapital | 17.39% |
| Bevakning av analytiker | Good |
| Senast uppdaterad | 05 May 2026 |
Senaste uppdateringarna om framtida tillväxt
Analysartikel • Nov 12
Genpact Limited Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next
Genpact Limited ( NYSE:G ) investors will be delighted, with the company turning in some strong numbers with its latest...Analysartikel • May 10
Earnings Beat: Genpact Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a sad week for Genpact Limited ( NYSE:G ), who've watched their investment drop 15% to US$42.46 in the week...Recent updates
Seeking Alpha • 2h
Genpact: Q1 Results Confirm Stable Growth Trends
Summary Genpact Limited delivered a strong Q1, beating consensus on all key metrics and demonstrating robust growth in its AI-driven Advanced Technology Solutions (ATS) segment. G trades at a steep discount to peers—over 50% on multiples—despite high margins, accelerating AI adoption, and consistent free cash flow generation. Management guides for stable Q2 and FY2026, with ATS revenue expected to grow 20%+ and total revenue/EPS growth aligning closely with consensus forecasts. I maintain a Buy rating with a $43 target (32% upside), citing underappreciated AI transition, resilient financials, and disciplined capital returns. Read the full article on Seeking Alpha
Analysuppdatering • May 08
G: AI Web Partnership And Ongoing Buybacks Will Support Future Shareholder Value
Analysts have slightly reduced their price target for Genpact to about $47.73 from roughly $48.18, reflecting small tweaks to fair value, discount rate, profit margin, and assumed future P/E that leave the overall valuation framework broadly intact. What's in the News Genpact and Parallel Web Systems announced a partnership that uses Parallel's AI native web agents and web search tools, delivered via API, to support information search, retrieval, and web intelligence across Genpact's business operations (Key Developments).
Ny analys • May 07
Agentic AI And Non FTE Models Will Shape Balanced Long Term Outcomes
Catalysts About Genpact Genpact provides business process and technology services, with a focus on data, AI and agentic solutions that help large enterprises run core operations. What are the underlying business or industry changes driving this perspective?Analysuppdatering • Apr 23
G: AI Partnership And Expanded Capital Returns Will Support Future Shareholder Value
Analysts have trimmed their price target on Genpact slightly to about $48.18 from roughly $48.64, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E that remain largely in line with prior views. What's in the News Genpact announced a partnership with Parallel Web Systems to use Parallel's AI native web agents and search tools, delivered via APIs, to support information search, retrieval, and web intelligence across its business operations, including use cases in insurance and sales.Analysuppdatering • Apr 09
G: AI Partnership And Capital Returns Will Support Stronger Future Shareholder Value
Analysts kept their fair value estimate for Genpact steady at about $48.64, citing only small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions that did not materially alter their price target view. What's in the News Genpact entered a partnership with Parallel Web Systems to use Parallel's AI native web agents and web search tools via API, aiming to improve information search, retrieval, and web intelligence across business operations, including insurance claims and sales use cases (Key Developments).Analysuppdatering • Mar 25
G: Buybacks And Higher Dividend Will Drive Stronger Future Shareholder Returns
Analysts now hold Genpact's fair value steady at $48.64, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E used to support their unchanged price target view. What's in the News From October 1, 2025 to February 25, 2026, Genpact repurchased 3,415,026 shares, representing 1.98% of its share count, for $145.95m under its ongoing buyback program.Analysuppdatering • Mar 11
G: Buybacks And Higher Dividend Will Support Attractive Future Shareholder Returns
Analysts have maintained their $48.64 price target on Genpact. They have made small adjustments to assumptions such as the discount rate, revenue growth, profit margin, and future P/E ratio, which refine rather than change their overall view.Analysuppdatering • Feb 25
G: Buybacks And Higher Dividend Will Support Attractive Long Term Returns
Analysts have trimmed their price target for Genpact by a small amount to $48.64 from $48.82, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E estimates. What's in the News Genpact issued earnings guidance for the first quarter of 2026, with net revenues projected between US$1.282b and US$1.294b and diluted EPS in the US$0.79 to US$0.80 range (company guidance).Analysartikel • Feb 09
Genpact (NYSE:G) Is Increasing Its Dividend To $0.1875
Genpact Limited's ( NYSE:G ) dividend will be increasing from last year's payment of the same period to $0.1875 on 31st...Analysuppdatering • Feb 07
G: Buybacks And Rising Dividends Will Support Steady Long Term Outcomes
Analysts have trimmed their price target for Genpact from about US$50.91 to roughly US$48.82, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. What's in the News Genpact reported that from October 1, 2025 to December 31, 2025, it repurchased 2,080,761 shares, representing 1.21% of shares, for US$100.06m under its ongoing buyback program.Analysuppdatering • Jan 10
G: AI Services And Buybacks Will Support Steady Long Term Outcomes
Analysts have nudged their price target on Genpact higher to about US$50.91 from roughly US$50.36, citing updated assumptions around revenue growth, profit margins, and future P/E levels. What's in the News Genpact updated full year 2025 guidance, now expecting net revenues of US$5.059b to US$5.071b, which the company describes as approximately 6.1% to 6.4% year over year as reported and 5.9% to 6.2% on a constant currency basis, compared with prior guidance of approximately 4.0% to 6.0% as reported (company guidance).Analysuppdatering • Dec 25
G: AI Services And Buybacks Will Support Balanced Long Term Performance
Analysts have nudged their price target for Genpact slightly higher to approximately 50.36 dollars from about 50.20 dollars, citing modestly improved long term growth and valuation assumptions, despite a small downward revision to profit margin forecasts. What's in the News Genpact reported that between July 1 and September 30, 2025, it repurchased 2,021,229 shares for about 89.99 million dollars, bringing total buybacks under its long running program to 68,817,622 shares, or 35.4 percent of shares outstanding, for roughly 2.29 billion dollars (company buyback update).Analysuppdatering • Dec 11
G: AI Insurance Workflow Suite And Buybacks Will Support Steady Future Performance
Analysts have modestly raised their price target on Genpact to $50.20, citing slight improvements in discount rate assumptions and forward valuation metrics while maintaining a stable fair value outlook. What's in the News Completed a major share repurchase tranche, buying back 2,021,229 shares in the latest quarter and reaching a cumulative 35.4% of shares repurchased under the multi year program announced in 2015 (company filing) Raised full year 2025 revenue guidance to $5.059 billion to $5.071 billion, implying 6.1% to 6.4% year over year growth as reported, with stronger outlooks for both Data Tech AI and Digital Operations segments (company guidance) Guided fourth quarter 2025 revenues to $1.298 billion to $1.311 billion, targeting 4.0% to 5.0% reported growth and diluted EPS of $0.78 to $0.80 (company guidance) Launched the Genpact Insurance Policy Suite for commercial and specialty insurance, an AI driven workflow offering built on Microsoft Azure and aimed at achieving up to 90% touchless submission clearance and significantly lower operating costs for insurers (product announcement) Valuation Changes Fair Value Estimate is unchanged at $50.20 per share, reflecting a stable fundamental outlook.Analysuppdatering • Nov 26
G: AI Will Drive Efficiency With Lower Costs In Insurance Workflows
Analysts have slightly lowered their price target for Genpact from $50.30 to $50.20. They cited modestly improved revenue growth and profit margin forecasts, balanced by a decrease in future price-to-earnings expectations.Analysartikel • Nov 12
Genpact Limited Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next
Genpact Limited ( NYSE:G ) investors will be delighted, with the company turning in some strong numbers with its latest...Analysuppdatering • Nov 07
G: Insurance AI Workflows Will Drive Efficiency and Cost Reduction
Analysts have maintained Genpact's fair value estimate at $50.30. They cite steady expectations for future growth and margins, despite a slight uptick in the discount rate and projected price-to-earnings ratio.Analysuppdatering • Oct 24
AI Solutions And Buybacks Will Shape Future Service Transformation
Analysts have lowered their price target for Genpact from $52.44 to $50.30, citing modest reductions in projected revenue growth and profit margin expectations. What's in the News Genpact launched the Genpact Insurance Policy Suite, an AI-powered workflow solution for commercial and specialty insurance.Analysartikel • Aug 06
Is It Time To Consider Buying Genpact Limited (NYSE:G)?
NYSE:G 1 Year Share Price vs Fair Value Explore Genpact's Fair Values from the Community and select yours Genpact...Analysartikel • Jul 16
Benign Growth For Genpact Limited (NYSE:G) Underpins Its Share Price
With a price-to-earnings (or "P/E") ratio of 14.6x Genpact Limited ( NYSE:G ) may be sending bullish signals at the...Analysartikel • Jul 03
Is Genpact (NYSE:G) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysartikel • Jun 19
Is There An Opportunity With Genpact Limited's (NYSE:G) 44% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Genpact fair value estimate is US$75.14 Current share price of...Analysartikel • May 10
Earnings Beat: Genpact Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a sad week for Genpact Limited ( NYSE:G ), who've watched their investment drop 15% to US$42.46 in the week...Seeking Alpha • Feb 23
Genpact: AI Explosion Exposure, But Not That Cheap Anymore (Rating Downgrade)
Summary Genpact's diverse client base and exposure to high-growth markets like AI and digital transformation have driven significant revenue and free cash flow growth. The company's proprietary AI platform, Genpact Cora, enhances customer experience and accelerates digital transformation, contributing to its solid financial performance. Recent dividend increases and a $500 million stock repurchase program indicate strong shareholder returns, potentially boosting future stock demand. Despite positive financials, the stock's current valuation limits upside potential, leading me to close my position due to decreased margin of safety. Read the full article on Seeking AlphaSeeking Alpha • Jan 05
Genpact Limited: The Overlooked Value Stock In Digital Transformation
Summary Genpact Limited (G) is a value investment with strong fundamentals, including consistent revenue growth, stable margins, and a conservative balance sheet. G's leadership in digital transformation and business process outsourcing, along with a diverse client base, supports its long-term investment potential. Macro factors like global economic conditions, inflation, and currency exchange rates can impact G's performance, but its operational efficiencies and recurring revenue model provide stability. G's intrinsic valuation suggests significant upside, with a target price of ~$61 per share, making it a compelling buy-and-hold opportunity. Read the full article on Seeking AlphaSeeking Alpha • Dec 16
Genpact: Steady Performer But Wait For A Wider Margin Of Safety
Summary Genpact's stock appreciated 25.83% since February 2024, outperforming the S&P 500, but the current price offers only a 5.41% margin of safety. Under new CEO Balkrishan Kalra, Genpact's 3+1 Execution Framework has driven significant revenue and earnings growth, particularly through Data-Tech-AI initiatives. The company raised its revenue and earnings guidance three times in 2024, reflecting strong performance and increased client engagement through strategic partnerships. Despite an improved fair value of $47.09, the current price of $44.67 suggests holding shares rather than buying due to a smaller margin of safety. Read the full article on Seeking AlphaPrognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2028 | 6,331 | 731 | N/A | 798 | 3 |
| 12/31/2027 | 5,832 | 665 | 778 | 870 | 12 |
| 12/31/2026 | 5,437 | 602 | 693 | 776 | 12 |
| 12/31/2025 | 5,080 | 552 | 724 | 813 | N/A |
| 9/30/2025 | 5,009 | 551 | 642 | 729 | N/A |
| 6/30/2025 | 4,929 | 538 | 562 | 650 | N/A |
| 3/31/2025 | 4,851 | 528 | 598 | 681 | N/A |
| 12/31/2024 | 4,767 | 514 | 530 | 615 | N/A |
| 9/30/2024 | 4,665 | 663 | 520 | 604 | N/A |
| 6/30/2024 | 4,589 | 648 | 460 | 537 | N/A |
| 3/31/2024 | 4,519 | 642 | 429 | 499 | N/A |
| 12/31/2023 | 4,477 | 631 | 432 | 491 | N/A |
| 9/30/2023 | 4,433 | 430 | 473 | 529 | N/A |
| 6/30/2023 | 4,408 | 408 | 542 | 593 | N/A |
| 3/31/2023 | 4,392 | 363 | 474 | 524 | N/A |
| 12/31/2022 | 4,371 | 353 | 389 | 444 | N/A |
| 9/30/2022 | 4,341 | 337 | 401 | 461 | N/A |
| 6/30/2022 | 4,246 | 343 | 381 | 445 | N/A |
| 3/31/2022 | 4,145 | 374 | 442 | 503 | N/A |
| 12/31/2021 | 4,022 | 369 | 637 | 694 | N/A |
| 9/30/2021 | 3,901 | 371 | 547 | 607 | N/A |
| 6/30/2021 | 3,820 | 354 | 585 | 649 | N/A |
| 3/31/2021 | 3,732 | 314 | 610 | 680 | N/A |
| 12/31/2020 | 3,709 | 308 | 504 | 584 | N/A |
| 9/30/2020 | 3,700 | 315 | 428 | 512 | N/A |
| 6/30/2020 | 3,653 | 318 | 378 | 480 | N/A |
| 3/31/2020 | 3,635 | 330 | 304 | 415 | N/A |
| 12/31/2019 | 3,521 | 305 | 319 | 428 | N/A |
| 9/30/2019 | 3,415 | 302 | N/A | 478 | N/A |
| 6/30/2019 | 3,274 | 287 | N/A | 411 | N/A |
| 3/31/2019 | 3,121 | 278 | N/A | 361 | N/A |
| 12/31/2018 | 3,001 | 282 | N/A | 340 | N/A |
| 9/30/2018 | 2,900 | 270 | N/A | 298 | N/A |
| 6/30/2018 | 2,861 | 270 | N/A | 293 | N/A |
| 3/31/2018 | 2,803 | 274 | N/A | 301 | N/A |
| 12/31/2017 | 2,737 | 263 | N/A | 359 | N/A |
| 9/30/2017 | 2,684 | 272 | N/A | 373 | N/A |
| 6/30/2017 | 2,624 | 268 | N/A | 375 | N/A |
| 3/31/2017 | 2,584 | 264 | N/A | 386 | N/A |
| 12/31/2016 | 2,571 | 270 | N/A | 346 | N/A |
| 9/30/2016 | 2,536 | 258 | N/A | 310 | N/A |
| 6/30/2016 | 2,505 | 257 | N/A | 299 | N/A |
| 3/31/2016 | 2,484 | 254 | N/A | 294 | N/A |
| 12/31/2015 | 2,461 | 240 | N/A | 327 | N/A |
| 9/30/2015 | 2,416 | 221 | N/A | 347 | N/A |
| 6/30/2015 | 2,386 | 200 | N/A | 293 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: G s prognostiserade vinsttillväxt ( 9.2% per år) är över sparkvoten ( 3.5% ).
Resultat vs marknad: G s intäkter ( 9.2% per år) förväntas växa långsammare än marknaden för US ( 16.6% per år).
Höga tillväxtresultat: G s intäkter förväntas växa, men inte avsevärt.
Intäkt vs marknad: G s intäkter ( 7% per år) förväntas växa långsammare än marknaden för US ( 11.5% per år).
Hög tillväxtintäkter: G s intäkter ( 7% per år) förväntas växa långsammare än 20% per år.
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: G s avkastning på eget kapital förväntas bli låg om 3 år ( 17.4 %).
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/07 05:18 |
| Aktiekurs vid dagens slut | 2026/05/07 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Genpact Limited bevakas av 23 analytiker. 12 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| David Koning | Baird |
| Keith Bachman | BMO Capital Markets Equity Research |
| Kunal Tayal | BofA Global Research |